Allergic Rhinitis (Nasal Allergies)

Clinical Trials for Nasal Allergies (Allergic Rhinitis)

Join Clinical Trials for Nasal Allergies (Allergic Rhinitis)

General Purpose: Many people suffer from the irritating symptoms associated with allergic rhinitis, better known as nasal allergies. The eye and nose symptoms that allergy sufferers contend with can interfere with one’s ability to live a normal life. The incidence of nasal allergies, and allergies in general, has steadily increased over the past few decades, which has driven the need for increasing research as well.

At present, many clinical trials seek to develop new and more effective methods of controlling nasal allergy symptoms, identifying underlying disorders that may be linked to nasal allergies (such as eczema and asthma), and identifying more effective methods of preventing the development of symptoms all together.

Continued … Allergic Rhinitis, Nasal Allergies (Click to Open)

Join Clinical Trials for Nasal Allergies (Allergic Rhinitis)

Clinical Trials for nasal allergies

What Will Nasal Allergy Clinical Trials Be Like?

When participating in a clinical trial for nasal allergies, a few common tests and procedures may be involved; however, the ultimate design of the particular study will Clinical Trials for nasal allergiesdetermine which specific procedures you will undergo.

Generally, some studies will involve a detailed history (provided by you to the study doctor) describing your symptoms, their severity, duration, and any noticeable patterns (i.e., variance by time of day, season, or upon exposure to triggers like pets or tree pollen). Some studies may require that you undergo skin-prick allergy testing to identify the entire allergen profile to which you are allergic.

For individuals who are unable to undergo skin-prick testing, blood tests may substituted. Blood tests may also be involved on a general level for all patients participating in allergy-related trials, in order to identify immune system markers, in particular one known as immunoglobulin E (IgE). In addition, some clinical trials may ask you to maintain a written or electronic diary in order to track your symptoms and exposures over a period of time.

Typical Nasal Allergy Clinical Trial Protocol:

Research related to nasal allergies might include the following types of trials:

  • A study designed to investigate the effectiveness of a newly-developed nasal spray medication at controlling nasal allergy symptoms.
  • A study designed to investigate the relationship between nasal allergies and the risk of asthma attacks.
  • A study designed to determine the association between nasal allergy symptom severity and level of fatigue.
  • A study designed to determine the risk of nasal allergies among individuals who overuse alcohol.
  • A clinical trial designed to compare the effectiveness of traditional medical therapies versus alternative medicine therapies at controlling nasal allergy symptoms.

Suggested Search Terms:

(Note: it is best to search using the term “allergic rhinitis” as that is the medically-appropriate term and will likely yield the most abundant and relevant results): “allergic rhinitis children,” “allergic rhinitis treatment,” “allergic rhinitis seasonal,” “allergic rhinitis immune system,” “allergic rhinitis prevention,” and “allergic rhinitis complications.” 

Current Search Term:

“Allergic Rhinitis”



Validation of an Allergic Rhinitis Control Test in Children


Condition:   Allergic Rhinitis
Intervention:   Other: Self Questionnaire
Sponsor:   University Hospital, Montpellier
Not yet recruiting - verified March 2017


Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis


Condition:   Perennial Allergic Rhinitis
Interventions:   Drug: SCRT;   Drug: Placebos
Sponsors:   Kyung Hee University Hospital at Gangdong;   Kyung Hee University Hospital;   Pusan National University Hospital;   Semyung University Affiliated Oriental Medical Hospital;   Dongguk University Ilsan Oriental Hospital
Recruiting - verified March 2017


Cellulose Powder Against Grass Pollen Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Device: Nasaleze;   Device: Placebo
Sponsors:   Nasaleze International Ltd;   Göteborg University
Completed - verified January 2017


Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: EMS Mometasone gel;   Drug: Mometasone spray nasal
Sponsor:   EMS
Not yet recruiting - verified November 2016


Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: EMS Mometasone gel;   Drug: Mometasone spray nasal
Sponsor:   EMS
Not yet recruiting - verified November 2016


Validation of an Allergic Rhinitis Control Test in Teenagers


Condition:   Allergic Rhinitis
Intervention:   Other: Self questionnaire for allergic rhinitis control
Sponsor:   University Hospital, Montpellier
Not yet recruiting - verified June 2016


Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Biological: ILIT with extract of causal allergen;   Biological: ILIT with normal saline;   Drug: Rescue medication for allergic rhinitis
Sponsors:   Gachon University Gil Medical Center;   Korea Research Foundation
Recruiting - verified July 2016


Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Nasal Beclomethasone Dipropionate;   Drug: CERCHIO 10 mg/ml OS
Sponsor:   Stefania La Grutta, MD
Recruiting - verified March 2017


Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)


Condition:   Seasonal Allergic Rhinitis
Interventions:   Drug: GSP 301 NS;   Drug: GOM NS;   Drug: GMM-2 NS;   Drug: GSP 301 Placebo NS
Sponsor:   Glenmark Specialty S.A.
Completed - verified March 2017


Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine


Condition:   Allergic Rhinitis
Interventions:   Drug: Bilastine;   Drug: Loratadine
Sponsor:   Universidade do Sul de Santa Catarina
Completed - verified May 2017


Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Placebo;   Drug: Fluticasone propionate;   Drug: Fluticasone/Azelastine nasal spray;   Procedure: Nasal Allergen Challenge
Sponsor:   University of Chicago
Recruiting - verified July 2016


Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients


Condition:   Allergic Rhinitis
Interventions:   Drug: HollisterStier;   Drug: Normal saline
Sponsors:   Gachon University Gil Medical Center;   Thermo Fisher Scientific
Terminated - verified August 2016


Efficacy of a Depigmented Extract of Phleum in Local Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Biological: DEPIGOID phleum;   Biological: DEPIGOID Placebo
Sponsors:   Plaza del Hospital Civil;   Laboratorios Leti, S.L.
Completed - verified November 2016


A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)


Condition:   Perennial Allergic Rhinitis
Interventions:   Drug: Desloratadine 5 mg;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2017


A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Biological: IGE-1;   Biological: IGE-2;   Biological: Saline
Sponsor:   Pfizer
Completed - verified May 2016


A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber


Condition:   Allergic Rhinitis
Interventions:   Drug: QAW039;   Drug: Montelukast;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Completed - verified November 2016


A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)


Condition:   Allergic Rhinitis
Interventions:   Drug: Montelukast 10 mg/loratadine 10 mg;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2017


A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber


Condition:   Seasonal Allergic Rhinitis
Interventions:   Drug: QAV680;   Drug: QAV680;   Drug: Mometasone Furoate
Sponsor:   Novartis
Completed - verified November 2016


Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)


Condition:   Allergic Rhinitis
Interventions:   Drug: Mometasone;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2017


Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529)


Condition:   Allergic Rhinitis
Interventions:   Drug: Mometasone furoate nasal spray (MFNS);   Drug: Matching placebo nasal spray
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2017


Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)


Condition:   Allergic Rhinitis
Interventions:   Drug: Mometasone furoate nasal spray (MFNS);   Drug: Matching placebo nasal spray
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2017


Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)


Condition:   Allergic Rhinitis
Interventions:   Drug: Mometasone furoate nasal spray (MFNS);   Drug: Matching placebo nasal spray
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified July 2016


An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever


Condition:   Allergic Rhinitis
Interventions:   Drug: QAX576;   Drug: Placebo
Sponsor:   Novartis
Completed - verified February 2017


Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)


Condition:   Allergic Rhinitis
Interventions:   Drug: 5-mg Desloratadine;   Drug: Placebo tablet
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2017


Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber


Condition:   Allergic Rhinitis
Intervention:   Drug: GW784568X
Sponsor:   GlaxoSmithKline
Completed - verified January 2017

Refine Your Search Advanced Search